SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (6928)8/12/1998 1:19:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Glad your back. Do you really think BPI or Neuprex will be confined to a niche market, are or you only trying to get a rise out of Tharos? I thought Meningococcemia was a form of sepsis, and this fact might stimulate off label use for sepsis.



To: StockDoc who wrote (6928)8/13/1998 3:26:00 AM
From: Tharos  Read Replies (2) | Respond to of 17367
 
We are experiencing some strong downwards pressure on the stock's price, but I doubt $2 is a realistic expectation. The stock has tested $3 three three different occasions in the past, and it held. This makes it a fairly strong support area. If $3 does not hold, then technically one could expect to be able to pick up the stock at something around $1 3/8 to 1 5/8. Still, it looks like threeish will hold. All imo.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News